The lower frequency of ANA and ANCA in the sera of patients with RA and their presence in a group of healthy donors indicated the reduced specificity of these autoantibodies in the context of RA, which is confirmed by the literature3. This evidence concerns the gene BTG3 and rheumatoid arthritis.